FDA-Inspected Site

Janssen Ortho LLC

15 FDA inspections are on record for Janssen Ortho LLC in Gurabo, United States.

483· Form 483 issued

Gurabo, United States · Last updated August 15, 2026

Overview

  • 15 FDA inspections are on record.
  • 11 inspections produced a Form 483.
  • The most recent recorded inspection date is 2026-06-05.

At a glance

Inspections

15

Form 483s

11

EIRs

4

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
1 Jun 2026 – 5 Jun 2026Human Drugs483View 483 →
13 Mar 2023 – 28 Mar 2023Human Drugs483View 483 →
6 Aug 2018 – 28 Aug 2018Human Drugs483View 483 →
15 May 2017 – 26 May 2017Human Drugs483View 483 →
11 May 2016 – 18 May 2016Human Drugs483View 483 →
22 Feb 2016 – 26 Feb 2016Human Drugs483On file
26 May 2015 – 29 May 2015Human Drugs483View 483 →
17 Jan 2013 – 22 Feb 2013Human Drugs483View 483 →
13 Jun 2011Not recorded483View 483 →
2 Sep 2010Not recordedClean
8 Jun 2009Not recorded483On file
21 Feb 2008Not recorded483On file

Observations on record

Form 483 observations cited at this site, most recent first.

5 Jun 2026
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Raquel Gonzalez Rivera, Yoriann M Cabrera Bartolomei, Elizabeth Rosa-Mercado

5 Jun 2026
21 CFR 211.165(a)

Testing and release for distribution

Cited by Raquel Gonzalez Rivera, Yoriann M Cabrera Bartolomei, Elizabeth Rosa-Mercado

5 Jun 2026
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Raquel Gonzalez Rivera, Yoriann M Cabrera Bartolomei, Elizabeth Rosa-Mercado

5 Jun 2026
21 CFR 211.194(a)(8)

Second person sign off

Cited by Raquel Gonzalez Rivera, Yoriann M Cabrera Bartolomei, Elizabeth Rosa-Mercado

5 Jun 2026
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Raquel Gonzalez Rivera, Yoriann M Cabrera Bartolomei, Elizabeth Rosa-Mercado

Investigators

FDA investigators tied to this site in the record.

Elizabeth Rosa-Mercado1 insp.
Jose A Lopez Rubet1 insp.
Jose A Moreno1 insp.
Arwa S El Hagrasy1 insp.
Vilmary Negron Rodriguez1 insp.
Ariel Cruz Figueroa1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations5x
21 CFR 211.160(b)Cited across public-safe Form 483 observations3x
21 CFR 211.22(d)Cited across public-safe Form 483 observations3x
21 CFR 211.68(b)Cited across public-safe Form 483 observations2x
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.134(c)Cited across public-safe Form 483 observations1x
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.165(a)Cited across public-safe Form 483 observations1x
21 CFR 211.188(b)(12)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(8)Cited across public-safe Form 483 observations1x
21 CFR 211.198(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x
21 CFR 211.65(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x
21 CFR 314.80(c)(1)(i)Cited across public-safe Form 483 observations1x
21 CFR 314.81(b)(1)(ii)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Janssen Ortho LLC's 11 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat